Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Well-differentiated Thyroid Cancer

NCT04948437 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04948437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04948437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Well-differentiated Thyroid Cancer
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
August 19, 2021
Completion date
October 31, 2026
Enrollment
103 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular thyroid cancer, papillary thyroid cancer, thyroid cancer